Inhibition of IGF2BP2 expression significantly reduces cell proliferation and invasion of NSCLC cells, and IGF2BP2 overexpressed reverses the anti-tumor effects of miR-485-5p in tumor cells47. Here, IGF2BP2 is linked to non-small cell lung carcinoma.